Chonluten 20 mg vial
- Peptide Plugs$50Listed priceCOA tested Oct 9, 2026
Chonluten is a short-peptide product commonly placed in the bioregulator category.
Also known as chonluten
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
1 of 1 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: Chonluten COAs →
What it is
Chonluten is a short-peptide product commonly placed in the bioregulator category.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
Chonluten is commonly sold or discussed for organ-specific bioregulator research and general wellness goals. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Peptide Plugs | Grade A- | 1 | 1 | $50 · 20 mg vialObserved Nov 14, 2026 |
| Core Peptides | Grade B+ | 1 | 1 | $51 · 20 mg vialEarlier observation Oct 20, 2026 |
| Biolongevity Labs | Grade B | 1 | 1 | $69.97 · 20 mg vialObserved Nov 14, 2026 |
1 tracked vendor lists Chonluten without a current offer: Swiss Chems (Grade C).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.